Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Accounts Payables (2020 - 2021)

Historic Accounts Payables for Design Therapeutics (DSGN) over the last 2 years, with Q3 2021 value amounting to $3.3 million.

  • Design Therapeutics' Accounts Payables changed N/A to $3.3 million in Q3 2021 from the same period last year, while for Sep 2021 it was $3.3 million, marking a year-over-year change of. This contributed to the annual value of $1.4 million for FY2020, which is N/A changed from last year.
  • According to the latest figures from Q3 2021, Design Therapeutics' Accounts Payables is $3.3 million.
  • Design Therapeutics' Accounts Payables' 5-year high stood at $3.3 million during Q3 2021, with a 5-year trough of $1.4 million in Q4 2020.